Danaher Corporation (DHR) is in Healthcare, Diagnostics & Research, based in United States, listed on NYSE. Market cap 152.87B USD. 52-week range 160.93 to 242.80 USD. Trailing P/E 38.8. Data as of 2026-10-09.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell ...